XOMAO Stock Analysis: Buy, Sell, or Hold?
XOMAO - XOMA Royalty Corporation Depositary Shares Rep Series B 8.375% Cumulative Preferred Stock
$25.63
0.22 (0.87%)
▲
5d:
+0.87%
30d:
+0.87%
90d:
+0.47%
HOLD
MODERATE Confidence
Analysis Updated: Mar 27, 2026 12:00 AM ET
Get Alerted When XOMAO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XOMAO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XOMAO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XOMAO is currently trading at $25.63, which is considered extended relative to its 30-day fair value range of $25.35 to $25.47.
Technical Outlook: Technically, XOMAO is in a downtrend. The price is currently testing key support at $25.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XOMAO is in a downtrend. The price is currently testing key support at $25.25. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$25.35 -
$25.47
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.3%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
Fair Price Analysis
30-Day Fair Range
$25.35 -
$25.47
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$25.25
Resistance Level
$25.62
Current Trend
Downtrend
Technical data as of
Mar 27, 2026
Fundamental Context
Revenue Growth (YoY)
57.9%
Earnings Growth (YoY)
-47.8%
Profit Margin
60.8%
Share & Embed Analysis
Last updated: March 30, 2026 10:27 AM ET
Data refreshes hourly during market hours. Next update: 11:27 AM
Data refreshes hourly during market hours. Next update: 11:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XOMAO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$449 | 59 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 56 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$101 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$26 | 56 HOLD |
